Mismatch Repair-Deficient Cancers Are Targets for Anti-PD-1 Therapy

Cancer Cell

Volumn 28, Issue 1, 2015, Pages 11-13

  Kelderman, Sander ^a   Schumacher, Ton N ^a   Kvistborg, Pia ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; PROGRAMMED DEATH 1 RECEPTOR INHIBITOR; UNCLASSIFIED DRUG; MONOCLONAL ANTIBODY; PDCD1 PROTEIN, HUMAN; PROGRAMMED DEATH 1 RECEPTOR;

CANCER IMMUNOTHERAPY; CANCER THERAPY; COLORECTAL CANCER; DNA DAMAGE; HUMAN; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; SHORT SURVEY; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; METABOLISM; NEOPLASMS; TUMOR MICROENVIRONMENT;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; DNA MISMATCH REPAIR; HUMANS; NEOPLASMS; PROGRAMMED CELL DEATH 1 RECEPTOR; TUMOR MICROENVIRONMENT;

EID: 84937404987     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2015.06.012     Document Type: Short Survey

References (10)

1. Dierssen J.W., de Miranda N.F., Ferrone S., van Puijenbroek M., Cornelisse C.J., Fleuren G.J., van Wezel T., Morreau H. BMC Cancer 2007, 7:33.
2. Kreiter S., Vormehr M., van de Roemer N., Diken M., Löwer M., Diekmann J., Boegel S., Schrörs B., Vascotto F., Castle J.C., et al. Nature 2015, 520:692-696.
3. Le D.T., Uram J.N., Wang H., Bartlett B.R., Kemberling H., Eyring A.D., Skora A.D., Luber B.S., Azad N.S., Laheru D., et al. N.Engl. J. Med. 2015, Published online June 25, 2015. 10.1056/NEJMoa1500596.
4. Linnemann C., van Buuren M.M., Bies L., Verdegaal E.M., Schotte R., Calis J.J., Behjati S., Velds A., Hilkmann H., Atmioui D.E., et al. Nat. Med. 2015, 21:81-85.
5. Llosa N.J., Cruise M., Tam A., Wick E.C., Hechenbleikner E.M., Taube J.M., Blosser L., Fan H., Wang H., Luber B., et al. Cancer Discov. 2014.
6. Rizvi N.A., Hellmann M.D., Snyder A., Kvistborg P., Makarov V., Havel J.J., Lee W., Yuan J., Wong P., Ho T.S., et al. Science 2015, 348:124-128.
7. Schumacher T.N., Schreiber R.D. Science 2015, 348:69-74.
8. Snyder A., Makarov V., Merghoub T., Yuan J., Zaretsky J.M., Desrichard A., Walsh L.A., Postow M.A., Wong P., Ho T.S., et al. N.Engl. J. Med. 2014, 371:2189-2199.
9. Topalian S.L., Hodi F.S., Brahmer J.R., Gettinger S.N., Smith D.C., McDermott D.F., Powderly J.D., Carvajal R.D., Sosman J.A., Atkins M.B., et al. N.Engl. J. Med. 2012, 366:2443-2454.
10. van Rooij N., van Buuren M.M., Philips D., Velds A., Toebes M., Heemskerk B., van Dijk L.J., Behjati S., Hilkmann H., El Atmioui D., et al. J.Clin. Oncol. 2013, 31:e439-e442.